Generic Name and Formulations:
Ivermectin 3mg, 6mg+; tabs; +scored.
Merck & Co., Inc.
Indications for STROMECTOL:
Intestinal strongyloidiasis due to Strongyloides stercoralis. Onchocerciasis due to immature Onchocerca volvulus.
Adults and Children:
Take with water. Give as a single dose. <15kg: not recommended. Strongyloidiasis: 200mcg/kg. Onchocerciasis: 150mcg/kg; may retreat after 3 months.
Hyperreactive onchodermatitis. Immunocompromised. Pregnancy (Cat.C), nursing mothers: not recommended.
Strongyloidiasis: dizziness, pruritus, GI disturbances. Onchocerciasis: Mazzotti reactions (eg, arthralgia/synovitis, swollen lymph nodes), ophthalmologic effects, pruritus, rash, fever, tachycardia, edema, hypotension.
Tabs 3mg—20; 6mg—10
Clinical Pain Advisor Articles
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Optimal Strategies for Opioid Weaning After Ambulatory Surgery
- Emergency Physicians Offer Recommendations for Identifying and Managing Opioid Use Disorder
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Higher PainDETECT Scores, Neuropathic Pain Preoperatively May Increase Risk for Chronic Pain Post-TKR
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Erenumab Reduces Monthly Migraine Days in Patients With Treatment-Resistant Migraine
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- Communication-Based Intervention Increases Goals-of-Care Discussions Between Physicians, Patients With Serious Illness